Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 mutations in human bladder cancer

W C Kusser1, X Miao, B W Glickman

  • 1University of Victoria, Department of Biology, British Columbia, Canada.

Environmental and Molecular Mutagenesis
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term exposure to particulate matter and all-cause and cause-specific mortality in an analysis of multiple Asian cohorts.

Environment international·2024
Same author

Transcriptomic changes in the nasal epithelium associated with diesel engine exhaust exposure.

Environment international·2020
Same author

No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models.

BMC cancer·2016
Same author

Benzene exposure and risk of lymphohaematopoietic cancers in 25,000 offshore oil industry workers.

British journal of cancer·2015
Same author

Outdoor, indoor, and personal black carbon exposure from cookstoves burning solid fuels.

Indoor air·2015
Same journal

Evaluating the Suitability of HepaRG Cells for Regulatory Micronucleus Testing: Comparing Results for a Diverse Set of 28 Chemicals to Regulatory Accepted TK6 Cells.

Environmental and molecular mutagenesis·2026
Same journal

Resveratrol Mitigates Haloacetaldehyde Disinfection By-Products (HAL-DBPs)-Induced Oocyte Developmental Toxicity via Mitochondria-Dependent Pathways.

Environmental and molecular mutagenesis·2026
Same journal

DZNep: A Methyltransferase Modulator for Disease Mitigation.

Environmental and molecular mutagenesis·2026
Same journal

Transcriptional Dysregulation of Histone Methyltransferase Genes and Chromosomal Instability Associated With Chronic Pesticide Exposure.

Environmental and molecular mutagenesis·2026
Same journal

Evaluation of Type 1 Error Rates in Duplex Sequencing for Mutagenicity Testing Using Vehicle Control Data and Simulation Analyses.

Environmental and molecular mutagenesis·2026
Same journal

Benzo[b]fluoranthene Induces Mutation Accumulation and Cancer-Relevant Mutational Signatures in Mouse Lung Alongside Steady State Levels of Chromosome Damage in Blood.

Environmental and molecular mutagenesis·2026
See all related articles

Mutations in the p53 tumor suppressor gene are linked to bladder cancer progression. This study identified p53 mutations in 23% of bladder tumors, particularly in higher-grade cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor gene is crucial in preventing cancer.
  • Understanding p53 mutations is key to comprehending carcinogenesis and tumor progression.

Purpose of the Study:

  • To investigate the status of p53 mutations in bladder cancer genomic DNA.
  • To analyze the spectrum and frequency of p53 mutations in relation to tumor grade.

Main Methods:

  • Utilized a two-stage polymerase chain reaction (PCR) for DNA amplification.
  • Employed Single Strand Conformation Polymorphism (SSCP) analysis for mutation detection.
  • Confirmed mutations through DNA sequencing of amplified PCR products.

Main Results:

Related Experiment Videos

  • Identified p53 mutations in 8 out of 35 (23%) bladder tumor samples.
  • Observed a higher frequency of p53 mutations in high-grade (III/IV) bladder cancers (46%) compared to low-grade (I/II) cancers (12%).
  • Detected a significant proportion of G:C to C:G transversions and double mutations.

Conclusions:

  • p53 mutations are prevalent in bladder cancer, especially in higher-grade tumors.
  • The findings support the role of p53 alterations in bladder tumor progression.
  • Further studies with larger cohorts are needed to establish statistical significance for high-grade associations.